3.3.1.900 html 279 416 1 false 92 0 false 8 false false R1.htm 101 - Document - Document and Entity Information Sheet http://www.merrimackpharma.com/taxonomy/role/DocumentandEntityInformation Document and Entity Information Cover 1 false false R2.htm 103 - Statement - Consolidated Balance Sheets Sheet http://www.merrimackpharma.com/taxonomy/role/StatementOfFinancialPositionClassified Consolidated Balance Sheets Statements 2 false false R3.htm 104 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.merrimackpharma.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 105 - Statement - Consolidated Statements of Operations and Comprehensive Loss Sheet http://www.merrimackpharma.com/taxonomy/role/StatementOfOtherComprehensiveIncome Consolidated Statements of Operations and Comprehensive Loss Statements 4 false false R5.htm 106 - Statement - Consolidated Statements of Non-Controlling Interest and Stockholders' Deficit Sheet http://www.merrimackpharma.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncome Consolidated Statements of Non-Controlling Interest and Stockholders' Deficit Statements 5 false false R6.htm 107 - Statement - Consolidated Statements of Cash Flows Sheet http://www.merrimackpharma.com/taxonomy/role/StatementOfCashFlowsIndirect Consolidated Statements of Cash Flows Statements 6 false false R7.htm 108 - Disclosure - Nature of the Business and Summary of Significant Accounting Policies Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock Nature of the Business and Summary of Significant Accounting Policies Notes 7 false false R8.htm 109 - Disclosure - Marketable Securities Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsInvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock Marketable Securities Notes 8 false false R9.htm 110 - Disclosure - Net Loss Per Common Share Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlock Net Loss Per Common Share Notes 9 false false R10.htm 111 - Disclosure - Product Revenue Reserves and Allowances Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsProductRevenueReservesAndAllowancesTextBlock Product Revenue Reserves and Allowances Notes 10 false false R11.htm 112 - Disclosure - License and Collaboration Agreements Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsCollaborativeArrangementDisclosureTextBlock License and Collaboration Agreements Notes 11 false false R12.htm 113 - Disclosure - Fair Value of Financial Instruments Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlock Fair Value of Financial Instruments Notes 12 false false R13.htm 114 - Disclosure - Consolidated Subsidiaries Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsConsolidatedSubsidiariesTextBlock Consolidated Subsidiaries Notes 13 false false R14.htm 115 - Disclosure - Goodwill and Intangible Assets, Net Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsGoodwillAndIntangibleAssetsDisclosureTextBlock Goodwill and Intangible Assets, Net Notes 14 false false R15.htm 116 - Disclosure - Property and Equipment, Net Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBlock Property and Equipment, Net Notes 15 false false R16.htm 117 - Disclosure - Accounts Payables, Accrued Expenses and Other Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock Accounts Payables, Accrued Expenses and Other Notes 16 false false R17.htm 118 - Disclosure - Borrowings Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlock Borrowings Notes 17 false false R18.htm 119 - Disclosure - Inventory Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlock Inventory Notes 18 false false R19.htm 120 - Disclosure - Stock Warrants Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsStockWarrantsDisclosureTextBlock Stock Warrants Notes 19 false false R20.htm 121 - Disclosure - Common Stock Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlock Common Stock Notes 20 false false R21.htm 122 - Disclosure - Stock-Based Compensation Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock Stock-Based Compensation Notes 21 false false R22.htm 123 - Disclosure - Income Taxes Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlock Income Taxes Notes 22 false false R23.htm 124 - Disclosure - Commitments and Contingencies Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock Commitments and Contingencies Notes 23 false false R24.htm 125 - Disclosure - Related Party Transactions Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsRelatedPartyTransactionsDisclosureTextBlock Related Party Transactions Notes 24 false false R25.htm 126 - Disclosure - Retirement Plan Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsCompensationAndEmployeeBenefitPlansTextBlock Retirement Plan Notes 25 false false R26.htm 127 - Disclosure - Selected Quarterly Financial Data (Unaudited) Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsQuarterlyFinancialInformationTextBlock Selected Quarterly Financial Data (Unaudited) Notes 26 false false R27.htm 128 - Disclosure - Nature of the Business and Summary of Significant Accounting Policies (Policies) Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlockPolicies Nature of the Business and Summary of Significant Accounting Policies (Policies) Policies http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock 27 false false R28.htm 129 - Disclosure - Nature of the Business and Summary of Significant Accounting Policies (Tables) Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlockTables Nature of the Business and Summary of Significant Accounting Policies (Tables) Tables http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock 28 false false R29.htm 130 - Disclosure - Marketable Securities (Tables) Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsInvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlockTables Marketable Securities (Tables) Tables http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsInvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock 29 false false R30.htm 131 - Disclosure - Net Loss Per Common Share (Tables) Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlockTables Net Loss Per Common Share (Tables) Tables http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlock 30 false false R31.htm 132 - Disclosure - Product Revenue Reserves and Allowances (Tables) Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsProductRevenueReservesAndAllowancesTextBlockTables Product Revenue Reserves and Allowances (Tables) Tables http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsProductRevenueReservesAndAllowancesTextBlock 31 false false R32.htm 133 - Disclosure - License and Collaboration Agreements (Tables) Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsCollaborativeArrangementDisclosureTextBlockTables License and Collaboration Agreements (Tables) Tables http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsCollaborativeArrangementDisclosureTextBlock 32 false false R33.htm 134 - Disclosure - Fair Value of Financial Instruments (Tables) Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlockTables Fair Value of Financial Instruments (Tables) Tables http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlock 33 false false R34.htm 135 - Disclosure - Goodwill and Intangible Assets, Net (Tables) Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsGoodwillAndIntangibleAssetsDisclosureTextBlockTables Goodwill and Intangible Assets, Net (Tables) Tables http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsGoodwillAndIntangibleAssetsDisclosureTextBlock 34 false false R35.htm 136 - Disclosure - Property and Equipment, Net (Tables) Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBlockTables Property and Equipment, Net (Tables) Tables http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsPropertyPlantAndEquipmentDisclosureTextBlock 35 false false R36.htm 137 - Disclosure - Accounts Payables, Accrued Expenses and Other (Tables) Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsAccountsPayableAndAccruedLiabilitiesDisclosureTextBlockTables Accounts Payables, Accrued Expenses and Other (Tables) Tables http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock 36 false false R37.htm 138 - Disclosure - Borrowings (Tables) Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlockTables Borrowings (Tables) Tables http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlock 37 false false R38.htm 139 - Disclosure - Inventory (Tables) Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlockTables Inventory (Tables) Tables http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlock 38 false false R39.htm 140 - Disclosure - Stock Warrants (Tables) Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsStockWarrantsDisclosureTextBlockTables Stock Warrants (Tables) Tables http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsStockWarrantsDisclosureTextBlock 39 false false R40.htm 141 - Disclosure - Common Stock (Tables) Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlockTables Common Stock (Tables) Tables http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlock 40 false false R41.htm 142 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlockTables Stock-Based Compensation (Tables) Tables http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock 41 false false R42.htm 143 - Disclosure - Income Taxes (Tables) Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlockTables Income Taxes (Tables) Tables http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlock 42 false false R43.htm 144 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlockTables Commitments and Contingencies (Tables) Tables http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock 43 false false R44.htm 145 - Disclosure - Selected Quarterly Financial Data (Unaudited) (Tables) Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsQuarterlyFinancialInformationTextBlockTables Selected Quarterly Financial Data (Unaudited) (Tables) Tables http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsQuarterlyFinancialInformationTextBlock 44 false false R45.htm 146 - Disclosure - Nature of the Business and Summary of Significant Accounting Policies - Additional Information (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureNatureOfTheBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformation Nature of the Business and Summary of Significant Accounting Policies - Additional Information (Detail) Details 45 false false R46.htm 147 - Disclosure - Nature of the Business and Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives of Property and Equipment Including Leasehold Improvements (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureNatureOfTheBusinessAndSummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentIncludingLeaseholdImprovements Nature of the Business and Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives of Property and Equipment Including Leasehold Improvements (Detail) Details 46 false false R47.htm 148 - Disclosure - Nature of the Business and Summary of Significant Accounting Policies - Schedules of Concentration of Risk by Risk Factor - Gross Sales Revenue (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureNatureOfTheBusinessAndSummaryOfSignificantAccountingPoliciesSchedulesOfConcentrationOfRiskByRiskFactorGrossSalesRevenue Nature of the Business and Summary of Significant Accounting Policies - Schedules of Concentration of Risk by Risk Factor - Gross Sales Revenue (Detail) Details 47 false false R48.htm 149 - Disclosure - Nature of the Business and Summary of Significant Accounting Policies - Schedules of Concentration of Risk by Risk Factor - Gross Accounts Receivable (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureNatureOfTheBusinessAndSummaryOfSignificantAccountingPoliciesSchedulesOfConcentrationOfRiskByRiskFactorGrossAccountsReceivable Nature of the Business and Summary of Significant Accounting Policies - Schedules of Concentration of Risk by Risk Factor - Gross Accounts Receivable (Detail) Details 48 false false R49.htm 150 - Disclosure - Marketable Securities - Additional Information (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureMarketableSecuritiesAdditionalInformation Marketable Securities - Additional Information (Detail) Details 49 false false R50.htm 151 - Disclosure - Marketable Securities - Schedule of Marketable Securities (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureMarketableSecuritiesScheduleOfMarketableSecurities Marketable Securities - Schedule of Marketable Securities (Detail) Details 50 false false R51.htm 152 - Disclosure - Net Loss Per Common Share - Additional Information (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformation Net Loss Per Common Share - Additional Information (Detail) Details 51 false false R52.htm 153 - Disclosure - Net Loss Per Common Share - Schedule of Securities Excluded from Computation of Diluted Loss Per Share (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfSecuritiesExcludedFromComputationOfDilutedLossPerShare Net Loss Per Common Share - Schedule of Securities Excluded from Computation of Diluted Loss Per Share (Detail) Details 52 false false R53.htm 154 - Disclosure - Product Revenue Reserves and Allowances - Summary of Product Revenue Reserve and Allowance Categories (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureProductRevenueReservesAndAllowancesSummaryOfProductRevenueReserveAndAllowanceCategories Product Revenue Reserves and Allowances - Summary of Product Revenue Reserve and Allowance Categories (Detail) Details 53 false false R54.htm 155 - Disclosure - License and Collaboration Agreements - Additional Information (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureLicenseAndCollaborationAgreementsAdditionalInformation License and Collaboration Agreements - Additional Information (Detail) Details 54 false false R55.htm 156 - Disclosure - License and Collaboration Agreements - Schedule of Revenue Recognized and Assets and Liabilities under Collaborative Arrangements (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureLicenseAndCollaborationAgreementsScheduleOfRevenueRecognizedAndAssetsAndLiabilitiesUnderCollaborativeArrangements License and Collaboration Agreements - Schedule of Revenue Recognized and Assets and Liabilities under Collaborative Arrangements (Detail) Details 55 false false R56.htm 157 - Disclosure - Fair Value of Financial Instruments - Schedule of Assets Measured at Fair Value on a Recurring Basis (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsScheduleOfAssetsMeasuredAtFairValueOnARecurringBasis Fair Value of Financial Instruments - Schedule of Assets Measured at Fair Value on a Recurring Basis (Detail) Details 56 false false R57.htm 158 - Disclosure - Fair Value of Financial Instruments - Additional Information (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsAdditionalInformation Fair Value of Financial Instruments - Additional Information (Detail) Details 57 false false R58.htm 159 - Disclosure - Consolidated Subsidiaries - Additional Information (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureConsolidatedSubsidiariesAdditionalInformation Consolidated Subsidiaries - Additional Information (Detail) Details 58 false false R59.htm 160 - Disclosure - Goodwill and Intangible Assets, Net - Additional Information (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsNetAdditionalInformation Goodwill and Intangible Assets, Net - Additional Information (Detail) Details 59 false false R60.htm 161 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Value of Goodwill, IPR&D and Intangible Assets (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsNetScheduleOfChangesInTheCarryingValueOfGoodwillIPRDAndIntangibleAssets Goodwill and Intangible Assets, Net - Schedule of Changes in the Carrying Value of Goodwill, IPR&D and Intangible Assets (Detail) Details 60 false false R61.htm 162 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Expected Amortization Expense for Intangible Assets for the Next Five-Year Period (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureGoodwillAndIntangibleAssetsNetScheduleOfExpectedAmortizationExpenseForIntangibleAssetsForTheNextFiveYearPeriod Goodwill and Intangible Assets, Net - Schedule of Expected Amortization Expense for Intangible Assets for the Next Five-Year Period (Detail) Details 61 false false R62.htm 163 - Disclosure - Property and Equipment, Net - Schedule of Property and Equipment, Net (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNet Property and Equipment, Net - Schedule of Property and Equipment, Net (Detail) Details 62 false false R63.htm 164 - Disclosure - Property and Equipment, Net - Additional Information (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosurePropertyAndEquipmentNetAdditionalInformation Property and Equipment, Net - Additional Information (Detail) Details 63 false false R64.htm 165 - Disclosure - Accounts Payable, Accrued Expenses and Other - Schedule of Accounts Payable, Accrued Expenses and Other (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureAccountsPayableAccruedExpensesAndOtherScheduleOfAccountsPayableAccruedExpensesAndOther Accounts Payable, Accrued Expenses and Other - Schedule of Accounts Payable, Accrued Expenses and Other (Detail) Details 64 false false R65.htm 166 - Disclosure - Borrowings - 2022 Notes - Additional Information (Detail) Notes http://www.merrimackpharma.com/taxonomy/role/DisclosureBorrowings2022NotesAdditionalInformation Borrowings - 2022 Notes - Additional Information (Detail) Details 65 false false R66.htm 167 - Disclosure - Borrowings - Convertible Notes - Additional Information (Detail) Notes http://www.merrimackpharma.com/taxonomy/role/DisclosureBorrowingsConvertibleNotesAdditionalInformation Borrowings - Convertible Notes - Additional Information (Detail) Details 66 false false R67.htm 168 - Disclosure - Borrowings - Loan Agreement - Additional Information (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureBorrowingsLoanAgreementAdditionalInformation Borrowings - Loan Agreement - Additional Information (Detail) Details 67 false false R68.htm 169 - Disclosure - Borrowings - Convertible Notes - Silver Creek - Additional Information (Detail) Notes http://www.merrimackpharma.com/taxonomy/role/DisclosureBorrowingsConvertibleNotesSilverCreekAdditionalInformation Borrowings - Convertible Notes - Silver Creek - Additional Information (Detail) Details 68 false false R69.htm 170 - Disclosure - Borrowings - Schedule of Future Minimum Payments under the Loans Payable (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureBorrowingsScheduleOfFutureMinimumPaymentsUnderTheLoansPayable Borrowings - Schedule of Future Minimum Payments under the Loans Payable (Detail) Details 69 false false R70.htm 171 - Disclosure - Inventory - Schedule of Inventory (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureInventoryScheduleOfInventory Inventory - Schedule of Inventory (Detail) Details 70 false false R71.htm 172 - Disclosure - Stock Warrants - Schedule of Common Stock Warrant Activity of the Company (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureStockWarrantsScheduleOfCommonStockWarrantActivityOfTheCompany Stock Warrants - Schedule of Common Stock Warrant Activity of the Company (Detail) Details 71 false false R72.htm 173 - Disclosure - Stock Warrants - Additional Information (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureStockWarrantsAdditionalInformation Stock Warrants - Additional Information (Detail) Details 72 false false R73.htm 174 - Disclosure - Common Stock - Additional Information (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureCommonStockAdditionalInformation Common Stock - Additional Information (Detail) Details 73 false false R74.htm 175 - Disclosure - Common Stock - Schedule of Shares Reserved for Future Issuance (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureCommonStockScheduleOfSharesReservedForFutureIssuance Common Stock - Schedule of Shares Reserved for Future Issuance (Detail) Details 74 false false R75.htm 176 - Disclosure - Stock-Based Compensation - Additional Information (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformation Stock-Based Compensation - Additional Information (Detail) Details 75 false false R76.htm 177 - Disclosure - Stock-Based Compensation - Schedule of Recognized Stock-Based Compensation Expense (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureStockBasedCompensationScheduleOfRecognizedStockBasedCompensationExpense Stock-Based Compensation - Schedule of Recognized Stock-Based Compensation Expense (Detail) Details 76 false false R77.htm 178 - Disclosure - Stock-Based Compensation - Schedule of Assumptions Used to Calculate Fair Value of Options Granted to Employees (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureStockBasedCompensationScheduleOfAssumptionsUsedToCalculateFairValueOfOptionsGrantedToEmployees Stock-Based Compensation - Schedule of Assumptions Used to Calculate Fair Value of Options Granted to Employees (Detail) Details 77 false false R78.htm 179 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivity Stock-Based Compensation - Summary of Stock Option Activity (Detail) Details 78 false false R79.htm 180 - Disclosure - Income Taxes - Schedule of Reconciliation of the Company's Effective Tax Rate to the Statutory Federal Income Tax Rate (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfTheCompanysEffectiveTaxRateToTheStatutoryFederalIncomeTaxRate Income Taxes - Schedule of Reconciliation of the Company's Effective Tax Rate to the Statutory Federal Income Tax Rate (Detail) Details 79 false false R80.htm 181 - Disclosure - Income Taxes - Schedule of Temporary Differences That Give Rise to Significant Net Deferred Tax Assets (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureIncomeTaxesScheduleOfTemporaryDifferencesThatGiveRiseToSignificantNetDeferredTaxAssets Income Taxes - Schedule of Temporary Differences That Give Rise to Significant Net Deferred Tax Assets (Detail) Details 80 false false R81.htm 182 - Disclosure - Income Taxes - Additional Information (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureIncomeTaxesAdditionalInformation Income Taxes - Additional Information (Detail) Details 81 false false R82.htm 183 - Disclosure - Income Taxes - Schedule of Changes in the Valuation Allowance (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureIncomeTaxesScheduleOfChangesInTheValuationAllowance Income Taxes - Schedule of Changes in the Valuation Allowance (Detail) Details 82 false false R83.htm 184 - Disclosure - Commitments and Contingencies - Additional Information (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformation Commitments and Contingencies - Additional Information (Detail) Details 83 false false R84.htm 185 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Lease Payments Under Non-cancelable Operating Leases (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentsUnderNoncancelableOperatingLeases Commitments and Contingencies - Schedule of Future Minimum Lease Payments Under Non-cancelable Operating Leases (Detail) Details 84 false false R85.htm 186 - Disclosure - Related Party Transactions - Additional Information (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformation Related Party Transactions - Additional Information (Detail) Details 85 false false R86.htm 187 - Disclosure - Retirement Plan - Additional Information (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureRetirementPlanAdditionalInformation Retirement Plan - Additional Information (Detail) Details 86 false false R87.htm 188 - Disclosure - Selected Quarterly Financial Data (Unaudited) - Schedule of Quarterly Financial Information (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureSelectedQuarterlyFinancialDataUnauditedScheduleOfQuarterlyFinancialInformation Selected Quarterly Financial Data (Unaudited) - Schedule of Quarterly Financial Information (Detail) Details http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsQuarterlyFinancialInformationTextBlockTables 87 false false All Reports Book All Reports mack-20151231.xml mack-20151231.xsd mack-20151231_cal.xml mack-20151231_def.xml mack-20151231_lab.xml mack-20151231_pre.xml true true